RenovaCare, a company based in New York City, is seeking FDA approval for the SkinGun, a device to treat burns using a patient’s own stem cells. Significant portions of skin can be destroyed in burn injuries, meaning that regenerative therapy is required to restore or replace the injured tissue. Current treatments for burns involve skin grafting, where healthy skin is removed from the patient and then cultured in a laboratory, sometimes for...